Skip to main content

This site is intended for healthcare professionals outside of the United States (US) and the United Kingdom (UK).

This site is created and funded by Novartis.

If you are an HCP from one of the countries listed, you may select your country from the list to be redirected to your specific site.

Change country or language (Non-US)
  • International
  • https://rltcare.novartis.com/
    Global
  • https://rltcare.novartis.com/de-de/
    Germany
  • https://rltcare.novartis.com/es-es/
    Spain
  • https://www.rltcare.novartis.com/fr-fr/
    France
  • https://www.rltcare.novartis.com/pt-pt/
    Portugal
  • https://www.rltcare.novartis.com/br-pt/
    Brazil
  • https://www.rltcare.novartis.com/jp-ja/
    Japan
Learn from experts to prepare your center

MDT Collaboration and Referral Pathways

In this video Prof Ken Herrmann discusses the collaboration between multidisciplinary teams (MDTs), focusing on PSMA-PET imaging and 177Lu-PSMA radioligand therapy in prostate cancer treatment. He highlights the history and scaling up of PSMA-PET in University Hospital Essen in Germany, emphasizing the collaborative approach between urology and nuclear medicine teams. He discusses the importance of MDTs in reviewing patient cases from various angles and involving specialists from different fields. He mentions the need for more theranostic centers, workforce training, and effective patient referral mechanisms. Additionally he outlines the fast-track mechanism available on their institution website for quick access to the PSMA program and the challenges of growing clinical demand and workforce issues. Overall, the video underscores the critical role of MDTs in patient management and the ongoing need for training and resource allocation in nuclear medicine.

Video Url

Get in touch

Our dedicated RLT specialist teams aim to streamline care coordination and alleviate uncertainty, ensuring you and your patients feel confident and supported every step of the way.